Clinical Trials Directory

Trials / Unknown

UnknownNCT03351530

Development of a Molecular Diagnosing Platform for Monitoring Oral Hygiene in Diabetic Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
General Biologicals Corporation · Industry
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Accepted

Summary

More than ninety percent of adults in Taiwan are suspected to carry periodontal disease, which causes bad breath, swollen and bleeding gums, plaque and even tooth loss. Half of the patients, however, are ignorance these clinical syndromes because of no obvious pain. A lot of researches show that periodontal disease is related to diabetes mellitus. Periodontal disease causes rise of blood sugar, and more than 3 times as diabetes mellitus patients as healthy people have serious periodontal disease.In this study, the investigators collect periodontal pocket and saliva samples of participants, and selecting six periodontal disease-associated bacteria strains, including Porphyromonas gingivalis (Pg), Fusobacterium nucleatum (Fn), Actinobacillus actinomycetemcomitans (Aa), Treponema denticola (Td), Prevotella intermedia (Pi) and Tannerella forsythia (Tf) as diagnostic markers. Participants will get bacteriostasis mouthwash at mouth 2. The investigators will compare the differences of blood biochemistry value and oral bacteria strains after using the mouthwash.Using real-time PCR and MALDI Biotyper, the investigators will establish the database of oral microorganisms in diabetes mellitus patients, providing periodontal disease clinical markers of high-risk groups and the basis for personal medicine of therapy in the future.

Conditions

Timeline

Start date
2017-05-18
Primary completion
2018-12-09
Completion
2019-02-09
First posted
2017-11-24
Last updated
2017-11-24

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03351530. Inclusion in this directory is not an endorsement.